Hepion Pharmaceuticals In...

NASDAQ: HEPA · Real-Time Price · USD
0.07
0.01 (22.59%)
At close: Jun 09, 2025, 3:45 PM

Hepion Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a 67.13K 77.46K 86.07K
Gross Profit
n/a -67.13K -77.46K -86.07K
Operating Income
-19.35M -48.45M -45.49M -30.4M
Interest Income
n/a n/a n/a n/a
Pretax Income
-16.16M -49.34M -45.08M -32.72M
Net Income
-13.19M -48.93M -42.2M -32.72M
Selling & General & Admin
7.5M 9.62M 10.35M 10.01M
Research & Development
11.85M 35.64M 33.27M 20.4M
Other Expenses
n/a 3.19M n/a n/a
Operating Expenses
19.35M 48.45M 43.62M 30.4M
Interest Expense
n/a 9.46K 10.16K 8.86K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
n/a 48.45M 43.62M 30.4M
Income Tax Expense
-2.97M -409.02K -2.88M 8.86K
Shares Outstanding (Basic)
122.89K 79K 70K 70K
Shares Outstanding (Diluted)
122.89K 79.42K 76.23K 70.29K
EPS (Basic)
-107.35 -616.07 -594.75 -465.52
EPS (Diluted)
-107.35 -616.07 -594.75 -465.52
EBITDA
-19.35M -49.26M -43.54M -30.32M
EBIT
-17.41M -49.33M -45.07M -30.4M
Depreciation & Amortization
-1.94M 67.13K 77.46K 86.07K